Literature DB >> 17624582

Acidic vesicles of the endo-exocytic pathways as targets for some anti-monoamine oxidase drugs.

Paolo Dell'Antone1, Meryem IbnLkayat, Denise Drago, Paolo Zatta.   

Abstract

Acidic vesicles are cytoplasmatic organelles delimited by a single lipoprotein membrane. They contain a large number of enzymes, mostly acidic hydrolases, catalysing various reactions at optimal acidic pH, capable of participating in intracellular digestion. In this paper, some anti-monoamine oxidase drugs (clorgyline, pargyline, amantadine and deprenyl), utilized as pharmacological treatment in some neurological disorders (e.g., Alzheimer's, Parkinson's etc. diseases), were tested for their ability to influence the pH of the acidic intracellular organelles with the aim of exploring their possible pharmacological action. Of the above mentioned drugs, clorgyline showed the most effective action in modifying the acidic vesicles' internal pH, followed by deprenyl, pargyline and amantadine. The effect was not ascribed to an increased proton conductance, but was most likely due to a weak base-like mechanism, in that they exhibit equilibria among species associated with H(+) ions and species lacking this association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624582     DOI: 10.1007/s11011-007-9054-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  22 in total

Review 1.  Selegiline for Alzheimer's disease.

Authors:  J Birks; L Flicker
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  Amantadine and memantine induce the expression of the glial cell line-derived neurotrophic factor in C6 glioma cells.

Authors:  Anne-Sophie Caumont; Jean-Noël Octave; Emmanuel Hermans
Journal:  Neurosci Lett       Date:  2005-11-18       Impact factor: 3.046

3.  Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

Authors:  M B Spina; G Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 5.  (-)Deprenyl (Selegiline): past, present and future.

Authors:  J Knoll
Journal:  Neurobiology (Bp)       Date:  2000

6.  R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.

Authors:  A Klegeris; P L McGeer
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

Review 7.  Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease.

Authors:  T Thomas
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

8.  Effects of aluminum speciation on murine neuroblastoma cells.

Authors:  P Zatta; M Perazzolo; L Facci; S D Skaper; B Corain; M Favarato
Journal:  Mol Chem Neuropathol       Date:  1992 Feb-Apr

Review 9.  The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective.

Authors:  Stephen Howard Pasternak; John William Callahan; Don Joseph Mahuran
Journal:  J Alzheimers Dis       Date:  2004-02       Impact factor: 4.472

10.  Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells.

Authors:  E A Mazzio; N Harris; K F Soliman
Journal:  Planta Med       Date:  1998-10       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.